API
Intermediates
Custom synthesis
Polypetides
Nucleotide series
 Apixaban |
| Aprepitant |
| Bepotastine besylate |
| Bisoprolol Fumarate |
| Clomifene Citrate |
| Cyclophosphamide |
| Darifenacin HBr |
| Dronedarone Base |
| Dronedarone Hydrochloride |
| Dasatinib |
| Dasatinib monohydrate |
| Deferasirox |
| Febuxostat |
| Fesoterodine fumarate |
| Ivabradine Hydrochloride |
| Indacaterol |
| Lafutidine |
| Leucovorin Calcium |
| L-Leucovorin Calcium |
| Methotrexate |
| Mizolastine |
| Olopatadine Hydrochloride |
| Prasugrel Hydrochloride |
| Prasugrel base |
| Paricalcitol |
| Rivaroxaban |
| Silodoxin |
| Tamoxifen Citrate |
| Voriconazole |
| Voglibose |
| Calcitonin |
| Desmopressin |
| Terlipressin |
| Enfuvirtide(T-20) |
| Eptifibatide |
| Glucagon |
| Gonadorelin |
| Goserelin |
| Hexarelin |
| Leuprorelin |
| Melanotan¢ò |
| Octreotide |
| Sermorelin |
| Somatostatin |
| Thymopentin |
| ¦Á1Thymosin alpha-1 |
| Triptorelin |
| Buserelin |
| Deslorelin |
| Fertirelin |
| Nafarelin |
| Alarelin |
| Histrelin |
| Bivalirudin |
| Nesiritide |
| Exenatide |
| Pramlintide |
| Liraglutide |
| 1H-Inden-2-amine,5,6-diethyl-2,3-dihydro-,hydrochloride (1:1) |
| 4-(4-Aminophenyl)morpholin-3-one(For Ivabradine) |
| (S)-N-(2, 3-Epoxypropyl)phthalimide(For Ivabradine) |
| 3,4-dimethoxy-N-methyl-bicyclo[4.2.0]octa-1,3,5-triene-7-methanamine hydrochloride (For Ivabradine) |
| 3-(3-chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-Benzazepin-2-one(For Ivabradine) |
| Methanone, (2-butyl-5-nitro-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl](For Dronedarone) |
| (5-Amino-2-butyl-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]-methanone dioxalate(For Dronedarone) |
| 2-Butyl-3-(4-methoxybenzoyl)-5-nitrobenzofuran(For Dronedarone) |
| 2-(n-Butyl)-3-(4-hydroxybenzoyl)-5-nitrobenzofuran(For Dronedarone) |
| N-(3-Chloropropyl)dibutylamine(For Dronedarone) |
| Ethyl 4-[(4-chlorophenyl)-2-pyridinylmethoxy]-1-piperidinecarboxylate(For Bepotastine) |
| 2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]-pyridine(For Bepotastine) |
| 2-[(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine 4-nitrobenzoate |
| 6-ethyl-5-fluoro-4-hydroxypyrimidine(For Voriconazole) |
| 4-chloro-6-ethyl-5-fluoropyrimidine(For Voriconazole) |
| (2R,3S/2S,3R)-3-(4-Chloro-5-fluoro-6-pyrimidinyl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol hydrochloride (For Voriconazole) |
| (2R,3S/2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (Racemic Voriconazole) |
| 4-[(2-carboxyphenyl)methoxy]benzeneacetic acid (For Olopatadine) |
| 6,11-dihydro-11-oxo-dibenz[b,e]oxepin-2-acetic acid(For Olopatadine) |
| [3-(dimethylamino)propyl]triphenylphosphonium bromide hydrobromide (For Olopatadine) |
| N-{4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene}phthalimide Maleate(For Lafutidine) |
| 2-Chloro-4-(piperidin-1-ylmethyl)pyridine Oxalate(For Lafutidine) |
| p-nitrophenyl 2-(furfurylsulfinyl)acetate(For Lafutidine) |
| 5,6,7,8-tetrahydro-2-naphthol(For Liranaftate) |
| 2,3-dihydrobenzofuranyl-5-acetic acid(For Darifenacin) |
| 5-(2-bromoethyl)-2,3-dihydrobenzofuran (For Darifenacin) |
| (s)-2,2-diphenyl-2-(1-tosylpyrrolidin-3-yl)acetonitrile(For Darifenacin) |
| 2,2-Diphenyl-2-[(3S)-pyrrolidin-3-yl]acetamide L-(+)-tartrate (For Darifenacin) |
| Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl-5-Thiazolecarboxylate(For Febuxostat) |
| Ethyl 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-Thiazolecarboxylate(For Febuxostat) |
| KRP-203£¬2-Amino-2-(2-(4-(3-benzyloxyphenylthio)-2-chlorophenyl)ethyl)-1,3-propanediol hydrochloride |
| 1H-Indole-7-boronic acid |
| 38. 2-(Chloromethyl)-3-(trifluoromethyl)pyridine |
| Aromadendrin |
| Diphenyleneiodonium Sulfate |
| Ethyl 4-bromothiazole-2-carboxylate |
| 1-(2-Methylpyrimidin-5-yl)ethanamine |
| 3-Chloromethyl-1,2,4-oxadiazole |
| 5-Chloropyrazine-2-carbaldehyde |
| 2,3-Pyridinedicarboxylicacid,4-amino-,dimethylester |
| Methyl 3-amino-5,6-dimethylpyrazine-2-carboxylate |
| Ethyl 3-amino-4-methoxythieno[2,3-b]pyridine-2-carboxylate |
| Ethyl 3-amino-5-nitrothieno[2,3-b]pyridine-2-carboxylate |
| 1-(5-Methylpyrimidin-2-yl)ethanol |
| 7-Chloro-5-methoxy-Thieno[3,2-b]pyridine |
| 2-Bromo-7-chloro-thieno[3,2-b]pyridine |
| 5-Bromo-2,3-dihydro-1H-inden-2-ol |
| 5,7-Dichloro-pyrido[4,3-d]pyrimidin-4(3H)-one |
| 3-Bromo-5-methyl-1H-pyrazole |
| Lumiracoxib |
| Asenapine |
| Lurasidone |
| Lurasidone |
| Lurasidone HCl |
| Posaconazole |
| Alvimopan |
| Rivastigmine tartrate |
| Rasagiline mesylate |
| H-L-Asu-OH |
| 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate(for Silodoxin) |
| 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate(for Silodoxin) |
| Cyclopropyl-2-fluorobenzyl ketone (for Prasugrel) |
| 5,6,7,7a-Tetrahydrothieno[3,2-c]pyridin-2(4H)-one 4-methylbenzenesulfonate (for Prasugrel) |
| 5,6,7,7a-Tetrahydro-5-(triphenylmethyl)thieno[3,2-c]pyridinone(for Prasugrel) |
| 4-(2-Hydroxyethyl)oxyindole(forRopinirole) |
| 2,3,4,6-Tetra-O-benzyl-alpha-D-glucose (forVoglibose) |
| Tetrabenzyl-voglibose(forVoglibose) |
| 4,5-Dimethoxy-1-cyanobenzocyclobutane |
| (S)-4-[1-(4-Chlorophenyl)-1-(2-pyridyl) methoxy] piperidine (For Bepotastine) |
| Landiolol HCl |
| ((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-hydroxyphenyl)propanoate |
| (S)-(+)-Glycidyl nosylate |
| N-(2-Aminoethyl)-4-morpholinecarboxamide ethanedioate |
| methotrexate disodium |
| 2,4,5,6-Tetraaminopyrimidine sulfate |
| 2,4-diamino-6-(bromomethyl)pteridine |
| 2,3,4,6-Tetra-O-benzyl-D-glucopyranose(for Voglibose) |
| 8-benzyloxy-5-(2-bromoacetyl)-2-(1H)-quinolinone) (for indacaterol) |
| (3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione(for Lurasidone) |
| (3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine(for Alvimopan) |
| (alphaS,3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethyl-alpha-(phenylmethyl)-1-piperidinepropanoic acid methyl ester(for Alvimopan ) |
| (R)-2-Benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoic acid(for Alvimopan) |
| Entecavir |
| 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine (For Bepotastine) |
| (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester |
| 2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one |
| Pidotimod |
| Raltitrexed |
| Pemetrexed disodium |
| olmesartan medoxomil |
| Doxofylline |
| Anagrelide Hydrochloride |
| Anagrelide |
| pramipexole dihydrochloride |
| Trans-(+/-)-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole-1-one |
| 11-chloro-2,3-dihydro-2-methyl-1H-dibenz[2,3;6,7]oxepino[4,5-c]pyrrol-1-one |
| (5-Chloro-2-phenoxyphenyl)acetic acid |
| Trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
| Cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
| Mixture of Trans and Cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
| 5-Chloro-2-Methyl-2,3-Dihydro-Benzo-[2,3:6,7]-Oxepino-[4,5-C]-pyrrole-(2H)-One |
| Dabigatran etexilate mesylate |
| Dabigatran etexilate |
| 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester |
| N-(4-Cyanophenyl)glycine |
| Benzoic acid, 4-(methylamino)-3-nitro |
| Ethyl 3-(pyridin-2-ylamino)propanoate |
| 2-(4-Methoxy-1,4-cyclohexadienyl)-2-propanol(for Nabilone) |
| 5-(1,1-Dimethylheptyl)resorcinol(for Nabilone) |
| 2-Hydroxyquinoline-4-carboxylic acid |
| Tetraisopropyl methylenediphosphonate(for Disodium clodronate) |
| Di(N-succinimidyl) adipate |
| TRI(ETHYLENE GLYCOL) DI-P-TOLUENESULFONATE |
| (S)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate(2S,3S)-2,3-dihydroxysuccinate |
| 5-[(2R,S)-2-AMINOPROPYL]-1-[3-(BENZOYLOXY)PROPYL]-2,3-DIHYDRO-1H-INDOLE-7-CARBONITRILE |
| (R)-tetrahydrothiophen-3-ol |
| ethyl 4-(4-hydroxypiperidin-1-yl) butanoate |
| (S)-(4-chlorophenyl)(pyridine-2yl)methanol (S form) |
| ethyl 4-(4-bromoypiperidin-1-yl)butanoate |
| Benzothiophene-3-carboxylic acid |
| Edoxaban tosylate monohydrate |
| Edoxaban |
| 4,5,6,7-tetrahydro-5-Methyl-Thiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride |
| Carbamic acid, N-[(1R,2S,5S)-2-[[2-[(5-chloro-2-pyridinyl) amino]-2-oxoacetyl]amino]-5-[(dimethylamino)carbonyl]cyclohexyl]-, 1,1-dimethylethyl ester |
| Carbamic acid,[(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]-,1,1-dimethylethyl ester |
| N-[3-fluoro-4-[(methylamino)carbonyl]phenyl]-2-methyl-alanine |
| N-[3-fluoro-4-[(methylamino)carbonyl]phenyl]-2-methyl-alanine methyl ester |
| 4-Isothiocyanato-2-(trifluoromethyl)benzonitrile |
| Enzalutamide |
| Naphthalene,1-cyclopropyl-4-isothiocyanato- |
| THR-PHE-GLN-ALA-TYR-PRO-LEU-ARG-GLU-ALA |
| esinurad |
| (R)-3-aminobutan-1-ol |
| 1533519-85-5 |
| Apremilast |
| N-(1,3-dioxo-1,3-dihydro-isobenzofuran-4-yl)acetamide |
| 4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione |
| Acotiamide hydrochloride |
| 138530-94-6 |
| MK-4305 |
| FYX 051 |
| 6-Ethylchenodeoxycholic acid |
|
We have established an integrated set of core technologies for the discovery of drugs that act upon targets.
Key elements of our discovery technology include
1) Cross high throughput screening of human protein chips, which express hundreds of human genes that possible act as drug targets, with our unique target focused chemistry libraries, which contains over 180,000 compounds;
2) Proprietary computational chemistry methods; an extensive database, which integrates biological and chemical information about our targets and compounds;
3) An extensive intellectual property portfolio consisting of publications and patents applications in both China and United states.
By integrating a number of scientific and drug development disciplines, we are able to efficiently discover and develop small molecule compounds, and therefore have a reduced likelihood of adverse side effects and clinical failure. |
